Press Releases

NEWS RELEASE 11.22.2023

AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE

NEWS RELEASE 11.10.2023

AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023

NEWS RELEASE 11.07.2023

AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023

NEWS RELEASE 11.07.2023

AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023

NEWS RELEASE 11.02.2023

AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)

NEWS RELEASE 11.01.2023

AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO

NEWS RELEASE 10.31.2023

AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS

NEWS RELEASE 10.25.2023

AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS

NEWS RELEASE 10.24.2023

AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND

NEWS RELEASE 10.22.2023

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

NEWS RELEASE 10.20.2023

AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER

NEWS RELEASE 10.19.2023

AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023

NEWS RELEASE 10.16.2023

AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023

NEWS RELEASE 10.06.2023

AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC

NEWS RELEASE 09.20.2023

AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS

NEWS RELEASE 09.11.2023

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 09.10.2023

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC

NEWS RELEASE 09.07.2023

AMGEN TO PRESENT AT THE MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 09.01.2023

AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

NEWS RELEASE 08.31.2023

AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 08.26.2023

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023

NEWS RELEASE 08.21.2023

AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING

NEWS RELEASE 08.03.2023

AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS

NEWS RELEASE 08.01.2023

AMGEN ANNOUNCES 2023 THIRD QUARTER DIVIDEND

NEWS RELEASE 07.31.2023

AMGEN ANNOUNCES WEBCAST OF 2023 SECOND QUARTER FINANCIAL RESULTS

NEWS RELEASE 06.21.2023

FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

NEWS RELEASE 06.09.2023

AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 06.04.2023

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023

NEWS RELEASE 06.01.2023

AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023

NEWS RELEASE 05.30.2023

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

NEWS RELEASE 05.26.2023

AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT

NEWS RELEASE 05.16.2023

AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS

NEWS RELEASE 05.09.2023

AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE

NEWS RELEASE 05.08.2023

NEW DATA FROM AMGEN'S PROLIA® (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE

NEWS RELEASE 05.03.2023

AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 04.27.2023

AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS

NEWS RELEASE 04.21.2023

AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS

NEWS RELEASE 04.19.2023

AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)

NEWS RELEASE 03.09.2023

AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE

NEWS RELEASE 03.07.2023

AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND

NEWS RELEASE 03.03.2023

AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE

NEWS RELEASE 03.01.2023

AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC

NEWS RELEASE 02.22.2023

AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND CARDIOVASCULAR RISK IN AFRICAN AMERICANS

NEWS RELEASE 02.09.2023

AMGEN TO PRESENT AT THE 2023 SVB SECURITIES GLOBAL BIOPHARMA CONFERENCE

NEWS RELEASE 02.02.2023

TEZSPIRE® APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH A NEW PRE-FILLED PEN

NEWS RELEASE 01.31.2023

AMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH QUARTER AND FULL YEAR 2022 EARNINGS WEBCAST

NEWS RELEASE 01.31.2023

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

NEWS RELEASE 01.31.2023

AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES

NEWS RELEASE 01.26.2023

AMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

NEWS RELEASE 01.06.2023

AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE NAMMI THERAPEUTICS TO RECEIVE THE THIRD AMGEN GOLDEN TICKET

NEWS RELEASE 01.04.2023

AMGEN TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Earnings